Den Europæiske Union -
dansk -
EMA (European Medicines Agency)
seffalair spiromax
teva b.v. - fluticasone propionate, salmeterol xinafoate - astma - medicin for obstruktiv sygdomme, - seffalair spiromax is indicated in the regular treatment of asthma in adults and adolescents aged 12 years and older not adequately controlled with inhaled corticosteroids and ‘as needed’ inhaled short-acting β₂ agonists.
Danmark -
dansk -
Lægemiddelstyrelsen (Danish Medicines Agency)
airflusal forspiro 50+500 mikrogram inhalationspulver, afdelt
2care4 aps - fluticasonpropionat, salmeterol - inhalationspulver, afdelt - 50+500 mikrogram
Danmark -
dansk -
Lægemiddelstyrelsen (Danish Medicines Agency)
airflusal forspiro 50+500 mikrogram inhalationspulver, afdelt
sandoz a/s - fluticasonpropionat, salmeterol - inhalationspulver, afdelt - 50+500 mikrogram
Danmark -
dansk -
Lægemiddelstyrelsen (Danish Medicines Agency)
airflusan forspiro 50+250 mikrogram inhalationspulver, afdelt
2care4 aps - fluticasonpropionat, salmeterol - inhalationspulver, afdelt - 50+250 mikrogram
Danmark -
dansk -
Lægemiddelstyrelsen (Danish Medicines Agency)
airflusan forspiro 50+500 mikrogram inhalationspulver, afdelt
2care4 aps - fluticasonpropionat, salmeterol - inhalationspulver, afdelt - 50+500 mikrogram
Danmark -
dansk -
Lægemiddelstyrelsen (Danish Medicines Agency)
seretide 25+250 mikrogram inhalationsspray, suspension
paranova danmark a/s - fluticasonpropionat, salmeterolxinafoat - inhalationsspray, suspension - 25+250 mikrogram
Danmark -
dansk -
Lægemiddelstyrelsen (Danish Medicines Agency)
seretide 25+125 mikrog./dosis inhalationsspray, suspension
orifarm a/s - fluticasonpropionat, salmeterolxinafoat - inhalationsspray, suspension - 25+125 mikrog./dosis
Danmark -
dansk -
Lægemiddelstyrelsen (Danish Medicines Agency)
seretide 25+125 mikrog./dosis inhalationsspray, suspension
chemvet pharma aps - fluticasonpropionat, salmeterolxinafoat - inhalationsspray, suspension - 25+125 mikrog./dosis
Danmark -
dansk -
Lægemiddelstyrelsen (Danish Medicines Agency)
seretide 25+250 mikrog./dosis inhalationsspray, suspension
glaxosmithkline pharma a/s - fluticasonpropionat, salmeterolxinafoat - inhalationsspray, suspension - 25+250 mikrog./dosis
Danmark -
dansk -
Lægemiddelstyrelsen (Danish Medicines Agency)
seretide 25+250 mikrog./dosis inhalationsspray, suspension
abacus medicine a/s - fluticasonpropionat, salmeterolxinafoat - inhalationsspray, suspension - 25+250 mikrog./dosis